A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

Keith Wheatley*, Alan K. Burnett, Anthony H. Goldstone, Richard G. Gray, Ian M. Hann, Christine J. Harrison, John K.H. Rees, Richard F. Stevens, Helen Walker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

352 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences